From Lab to Launch by Qualio artwork

Rethinking Your Market Access Strategy with Dinesh Kabaleeswaran, Sr. Dir. of Insights and Advisory at MMIT

From Lab to Launch by Qualio

English - March 07, 2022 14:00 - 20 minutes - 14.1 MB
Life Sciences Science Business Entrepreneurship life sciences medical device biotech quality management entrepreneurship Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: European Market Strategy, Acquisitions and Disrupting the Drug Discovery Value Chain with Tanja Dowe from Debiopharm Innovation Fund
Next Episode: Restoring Hearing Loss with Novel Therapeutics with Laurence Reid CEO of Decibel Tx

Today's episode we explore the ins and outs of market access strategy with Dinesh Kabaleeswaran,  Sr. Dir. of Insights and Advisory at MMIT. Learn more about how to improve market access strategy with better data, payer and buyer insights, and what the medical device side of life sciences can learn from pharma's approach and speed to market access. 

About Dinesh:
Dinesh Kabaleeswaran leads MMIT's Advisory & Insights teams, which provide market access context and a market research narrative for MMIT's data and technology products. Dinesh has more than seven years of managed care experience, advising large biopharmaceutical clients on pre- and post-launch strategies across oncology, non-oncology and immunology therapeutic areas. Dinesh holds a master’s in bioengineering from the University of Pennsylvania.

Twitter: https://twitter.com/DineshKannanKa2
LinkedIn: https://www.linkedin.com/in/dineshkannan/

Recent articles by Dinesh:
The Power of Partnerships: Why Pharma Needs to Redefine its Role With IDNs (Drug Channels)
Market Access Speed Is the Next Critical Differentiator for Pharma Manufacturers (PharmExec) 

About MMIT
MMIT is regarded as a trusted go-to-market partner that identifies barriers to patient access and helps coordinate major stakeholders to move therapies from pipeline to prescription—answering the “what” of how payers cover therapies and the “why” behind those decisions. MMIT’s product portfolio has been built by listening to our clients, and with expert teams of pharmacists, clinicians, data specialists and market researchers who provide foresight, clarity and confidence. This is the hallmark of who we are and who we will always be.

MMIT website: Mmitnetwork.com
MMIT on LinkedIn: https://www.linkedin.com/company/mmit-managed-markets-insight-&-technology-/

Show notes
Qualio
Press Release: MMIT Announces Game-Changing Solution for Life Sciences Companies
MMIT's Reality Check series

Previous episodes: https://www.qualio.com/from-lab-to-launch-podcast

Apply to be on the show: https://forms.gle/uUH2YtCFxJHrVGeL8

Music by keldez

Qualio website:
https://www.qualio.com/

Previous episodes:
https://www.qualio.com/from-lab-to-launch-podcast

Apply to be on the show:
https://forms.gle/uUH2YtCFxJHrVGeL8

Music by keldez

Twitter Mentions